{"id":4026,"date":"2023-06-12T17:19:17","date_gmt":"2023-06-12T21:19:17","guid":{"rendered":"https:\/\/www.millerthomson.com\/deals-cases\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/"},"modified":"2026-04-23T19:12:10","modified_gmt":"2026-04-23T23:12:10","slug":"zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover","status":"publish","type":"deals-cases","link":"https:\/\/www.millerthomson.com\/en\/deals-cases\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/","title":{"rendered":"ZYUS Life Sciences successfully completes brokered subscription receipt financing and reverse takeover"},"content":{"rendered":"<p>On June 6, 2023, ZYUS Life Sciences Inc. (&#8220;ZYUS&#8221;), a private Canadian life sciences company, and Phoenix Canada Oil Company Limited (TSX-V:PCO) (the &#8220;Company&#8221;) announced the closing of a brokered subscription receipt financing for aggregate gross proceeds of approximately $20,130,131 through the issuance 12,581,332 subscription receipts of ZYUS at price of $1.60 per subscription receipt.<\/p>\n<p>On June 12, 2023, ZYUS and the Company announced the completion of the previously announced reverse takeover transaction in accordance with the terms of an arrangement agreement dated November 15, 2022, as amended (the \u201cArrangement Agreement\u201d), pursuant to which the Company and ZYUS completed a business combination by way of a plan of arrangement.<\/p>\n<p>The financing was led by Stifel Nicolaus Canada Inc., Haywood Securities Inc. and Roth Canada Inc, acting as co-lead agents and joint bookrunners.<\/p>\n<p>Miller Thomson advised the agents on the financing and reverse-takeover, with a team led by Lawrence Wilder and comprised of Adam Kline, Ian Polisuk, Connor Broude, Andrea Chiu (Corporate\/M&amp;A).<\/p>\n","protected":false},"author":92,"template":"","class_list":["post-4026","deals-cases","type-deals-cases","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ZYUS Life Sciences successfully completes brokered subscription receipt financing and reverse takeover | Miller Thomson<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.millerthomson.com\/en\/deals-cases\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ZYUS Life Sciences successfully completes brokered subscription receipt financing and reverse takeover | Miller Thomson\" \/>\n<meta property=\"og:description\" content=\"Counsel to Stifel GMP\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.millerthomson.com\/en\/deals-cases\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/\" \/>\n<meta property=\"og:site_name\" content=\"Miller Thomson\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/MillerThomsonLaw\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-23T23:12:10+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@millerthomson\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.millerthomson.com\/en\/deals-cases\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/\",\"url\":\"https:\/\/www.millerthomson.com\/en\/deals-cases\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/\",\"name\":\"ZYUS Life Sciences successfully completes brokered subscription receipt financing and reverse takeover | Miller Thomson\",\"isPartOf\":{\"@id\":\"https:\/\/www.millerthomson.com\/en\/#website\"},\"datePublished\":\"2023-06-12T21:19:17+00:00\",\"dateModified\":\"2026-04-23T23:12:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.millerthomson.com\/en\/deals-cases\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.millerthomson.com\/en\/deals-cases\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.millerthomson.com\/en\/deals-cases\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.millerthomson.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Deals and Cases\",\"item\":\"https:\/\/www.millerthomson.com\/en\/deals-cases\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"ZYUS Life Sciences successfully completes brokered subscription receipt financing and reverse takeover\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.millerthomson.com\/en\/#website\",\"url\":\"https:\/\/www.millerthomson.com\/en\/\",\"name\":\"Miller Thomson\",\"description\":\"National law firm providing business law expertise and litigation and disputes services for businesses across Canada since 1957.\",\"publisher\":{\"@id\":\"https:\/\/www.millerthomson.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.millerthomson.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.millerthomson.com\/en\/#organization\",\"name\":\"Miller Thomson\",\"url\":\"https:\/\/www.millerthomson.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.millerthomson.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.millerthomson.com\/wp-content\/uploads\/2024\/10\/miller-thomson.svg\",\"contentUrl\":\"https:\/\/www.millerthomson.com\/wp-content\/uploads\/2024\/10\/miller-thomson.svg\",\"width\":380,\"height\":50,\"caption\":\"Miller Thomson\"},\"image\":{\"@id\":\"https:\/\/www.millerthomson.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/MillerThomsonLaw\/\",\"https:\/\/x.com\/millerthomson\",\"https:\/\/www.linkedin.com\/company\/miller-thomson-llp\/\",\"https:\/\/www.youtube.com\/@millerthomson\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ZYUS Life Sciences successfully completes brokered subscription receipt financing and reverse takeover | Miller Thomson","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.millerthomson.com\/en\/deals-cases\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/","og_locale":"en_US","og_type":"article","og_title":"ZYUS Life Sciences successfully completes brokered subscription receipt financing and reverse takeover | Miller Thomson","og_description":"Counsel to Stifel GMP","og_url":"https:\/\/www.millerthomson.com\/en\/deals-cases\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/","og_site_name":"Miller Thomson","article_publisher":"https:\/\/www.facebook.com\/MillerThomsonLaw\/","article_modified_time":"2026-04-23T23:12:10+00:00","twitter_card":"summary_large_image","twitter_site":"@millerthomson","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.millerthomson.com\/en\/deals-cases\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/","url":"https:\/\/www.millerthomson.com\/en\/deals-cases\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/","name":"ZYUS Life Sciences successfully completes brokered subscription receipt financing and reverse takeover | Miller Thomson","isPartOf":{"@id":"https:\/\/www.millerthomson.com\/en\/#website"},"datePublished":"2023-06-12T21:19:17+00:00","dateModified":"2026-04-23T23:12:10+00:00","breadcrumb":{"@id":"https:\/\/www.millerthomson.com\/en\/deals-cases\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.millerthomson.com\/en\/deals-cases\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.millerthomson.com\/en\/deals-cases\/zyus-life-sciences-successfully-completes-brokered-subscription-receipt-financing-and-reverse-takeover\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.millerthomson.com\/en\/"},{"@type":"ListItem","position":2,"name":"Deals and Cases","item":"https:\/\/www.millerthomson.com\/en\/deals-cases\/"},{"@type":"ListItem","position":3,"name":"ZYUS Life Sciences successfully completes brokered subscription receipt financing and reverse takeover"}]},{"@type":"WebSite","@id":"https:\/\/www.millerthomson.com\/en\/#website","url":"https:\/\/www.millerthomson.com\/en\/","name":"Miller Thomson","description":"National law firm providing business law expertise and litigation and disputes services for businesses across Canada since 1957.","publisher":{"@id":"https:\/\/www.millerthomson.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.millerthomson.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.millerthomson.com\/en\/#organization","name":"Miller Thomson","url":"https:\/\/www.millerthomson.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.millerthomson.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.millerthomson.com\/wp-content\/uploads\/2024\/10\/miller-thomson.svg","contentUrl":"https:\/\/www.millerthomson.com\/wp-content\/uploads\/2024\/10\/miller-thomson.svg","width":380,"height":50,"caption":"Miller Thomson"},"image":{"@id":"https:\/\/www.millerthomson.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/MillerThomsonLaw\/","https:\/\/x.com\/millerthomson","https:\/\/www.linkedin.com\/company\/miller-thomson-llp\/","https:\/\/www.youtube.com\/@millerthomson"]}]}},"_links":{"self":[{"href":"https:\/\/www.millerthomson.com\/en\/wp-json\/wp\/v2\/deals-cases\/4026","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.millerthomson.com\/en\/wp-json\/wp\/v2\/deals-cases"}],"about":[{"href":"https:\/\/www.millerthomson.com\/en\/wp-json\/wp\/v2\/types\/deals-cases"}],"author":[{"embeddable":true,"href":"https:\/\/www.millerthomson.com\/en\/wp-json\/wp\/v2\/users\/92"}],"version-history":[{"count":1,"href":"https:\/\/www.millerthomson.com\/en\/wp-json\/wp\/v2\/deals-cases\/4026\/revisions"}],"predecessor-version":[{"id":49574,"href":"https:\/\/www.millerthomson.com\/en\/wp-json\/wp\/v2\/deals-cases\/4026\/revisions\/49574"}],"wp:attachment":[{"href":"https:\/\/www.millerthomson.com\/en\/wp-json\/wp\/v2\/media?parent=4026"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}